| Name | Title | Contact Details |
|---|
Acumen Research Group Inc. is a London, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For nearly 50 years, Acts Retirement-Life Communities has met the retirement lifestyle and healthcare needs of older adults living in our communities. Our first community opened in 1972 with the vision of a church pastor and his congregation whose goal was to create an environment that offered seniors a rewarding lifestyle and high quality healthcare if ever needed. Today, Acts is the largest not-for-profit owner, operator and developer of continuing care retirement communities (CCRCs) in the United States. Our 26 communities currently serve more than 10,000 residents in nine states. Our vision for Acts is to have The Acts Culture of Loving-Kindness be the basic fiber of our daily practice to meet the needs of those we serve. As we continue to grow, we`re looking for dedicated and compassionate individuals to join our team who help to carry out our mission of serving older adults. We have been able to provide an unparalleled quality of life for our residents by recruiting and hiring great people who understand our vision and strive to be a part of it. We are convinced that the secret to our success is our employees who work as a team each day to make a positive difference in the lives of our residents. It is for this reason that we provide a working environment based on fair employment practices, competitive pay and benefits, career opportunities and other programs designed to help our employee`s achieve their professional goals.
Pancreatic Cancer Canada is a national foundation dedicated to improving pancreatic cancer survival rates through research, awareness, education, and advocacy in Canada.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.
KishHealth System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. KishHealth System is based in Dekalb, IL. You can find more information on KishHealth System at www.kishhealth.org